Asset Allocation

As of December 31, 2025.
Type % Net
Cash 0.00%
Stock 60.96%
Bond 20.30%
Convertible 0.00%
Preferred 0.13%
Other 18.61%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2025
Large 45.98%
Mid 21.25%
Small 32.77%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 77.76%    % Emerging Markets: 3.24%    % Unidentified Markets: 19.00%

Americas 58.22%
57.20%
Canada 22.60%
United States 34.60%
1.02%
Mexico 1.02%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 14.86%
United Kingdom 0.00%
14.86%
Germany 4.08%
Ireland 1.13%
Netherlands 3.31%
Spain 0.72%
Sweden 2.79%
Switzerland 2.83%
0.00%
0.00%
Greater Asia 7.92%
Japan 3.95%
0.00%
1.75%
Hong Kong 1.75%
2.22%
China 2.22%
Unidentified Region 19.00%

Bond Credit Quality Exposure

AAA 0.55%
AA 2.72%
A 15.15%
BBB 31.15%
BB 7.04%
B 13.08%
Below B 6.28%
    CCC 6.28%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 24.02%
Short Term 0.00%
As of December 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
38.80%
Materials
10.10%
Consumer Discretionary
19.17%
Financials
5.73%
Real Estate
3.80%
Sensitive
38.58%
Communication Services
3.49%
Energy
5.61%
Industrials
21.35%
Information Technology
8.12%
Defensive
20.75%
Consumer Staples
1.06%
Health Care
18.11%
Utilities
1.57%
Not Classified
1.87%
Non Classified Equity
1.87%
Not Classified - Non Equity
0.00%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 0.55%
Corporate 87.37%
Securitized 0.00%
Municipal 0.00%
Other 12.08%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
11.63%
Less than 1 Year
11.63%
Intermediate
80.76%
1 to 3 Years
35.25%
3 to 5 Years
28.01%
5 to 10 Years
17.51%
Long Term
7.60%
10 to 20 Years
3.31%
20 to 30 Years
0.08%
Over 30 Years
4.21%
Other
0.00%
As of December 31, 2025
View Bond Maturity Exposure
Start Trial